NOVAVAX INC - FORM 10-K - EX-23.1 - EXHIBIT 23.1 - March 11, 2020

Attached files

file filename
EX-32.2 - EXHIBIT 32.2 - NOVAVAX INCtm205233d1_ex32-2.htm
EX-32.1 - EXHIBIT 32.1 - NOVAVAX INCtm205233d1_ex32-1.htm
EX-31.2 - EXHIBIT 31.2 - NOVAVAX INCtm205233d1_ex31-2.htm
EX-31.1 - EXHIBIT 31.1 - NOVAVAX INCtm205233d1_ex31-1.htm
EX-21 - EXHIBIT 21 - NOVAVAX INCtm205233d1_ex21.htm
EX-4.3 - EXHIBIT 4.3 - NOVAVAX INCtm205233d1_ex4-3.htm
10-K - FORM 10-K - NOVAVAX INCtm205233-1_10k.htm

Exhibit 23.1

 

 

Consent of Independent Registered Public Accounting Firm

 

We consent to the incorporation by reference in the following Registration Statements:

 

(1)Registration Statement (Form S-3 No. 333-235761) pertaining to Novavax, Inc. common stock, preferred stock, warrants and units,
(2)Registration Statement (Form S-8 No. 333-233133) pertaining to the Novavax, Inc. stock incentive plan and 2013 employee stock purchase plan,
(3)Registration Statement (Form S-8 No. 333-226498) pertaining to the Novavax, Inc. stock incentive plan and 2013 employee stock purchase plan,
(4)Registration Statement (Form S-3 No. 333-222365) pertaining to Novavax, Inc. common stock, preferred stock, warrants and units,
(5)Registration Statement (Form S-8 No. 333-219829) pertaining to the Novavax, Inc. stock incentive plan,
(6)Registration Statement (Form S-8 No. 333-213069) pertaining to the Novavax, Inc. stock incentive plan and 2013 employee stock purchase plan,
(7)Registration Statement (Form S-8 No. 333-206354) pertaining to the Novavax, Inc. stock incentive plan,
(8)Registration Statement (Form S-8 No. 333-198121) pertaining to the Novavax, Inc. stock incentive plan,
(9)Registration Statement (Form S-8 No. 333-190600) pertaining to the Novavax, Inc. stock incentive plan,
(10)Registration Statement (Form S-8 No. 333-190599) pertaining to the Novavax, Inc. 2013 employee stock purchase plan,
(11)Registration Statement (Form S-8 No. 333-183113) pertaining to the Novavax, Inc. stock incentive plan,
(12)Registration Statement (Form S-8 No. 333-145298) pertaining to the Novavax, Inc. stock incentive plan,
(13)Registration Statement (Form S-8 No. 333-130990) pertaining to the Novavax, Inc. stock incentive plan,
(14)Registration Statement (Form S-8 No. 333-110401) pertaining to the Novavax, Inc. stock incentive plan,
(15)Registration Statement (Form S-8 No. 333-97931) pertaining to the Novavax, Inc. stock incentive plan,
(16)Registration Statement (Form S-8 No. 333-46000) pertaining to the Novavax, Inc. stock incentive plan,
(17)Registration Statement (Form S-8 No. 333-77611) pertaining to the Novavax, Inc. stock incentive plan,
(18)Registration Statement (Form S-8 No. 333-03384) pertaining to the Novavax, Inc. stock incentive plan,
(19)Registration Statement (Form S-8 No. 33-80279) pertaining to the Novavax, Inc. stock incentive plan, and
(20)Registration Statement (Form S-8 No. 33-80277) pertaining to the Novavax, Inc. stock incentive plan

 

of our reports dated March 11, 2020, with respect to the consolidated financial statements of Novavax, Inc., and the effectiveness of internal control over financial reporting of Novavax, Inc., included in this Annual Report (Form 10-K) of Novavax, Inc. for the year ended December 31, 2019.

 

 

/s/ Ernst & Young LLP

 

Tysons, Virginia

March 11, 2020

 

 

 

NOVAVAX INC Reports